Kunizou Mori

Title: Kunizou Mori: Innovator in Tissue Plasminogen Activator Purification

Introduction

Kunizou Mori is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of biochemistry, particularly in the purification of tissue plasminogen activator (tPA). With a total of 2 patents, his work has implications for medical treatments and research.

Latest Patents

Mori's latest patents focus on innovative purification procedures for tPA. The first patent describes a purification procedure of tPA from crude preparations. This method allows for the isolation of tPA species with specific molecular weights from a crude tPA preparation by utilizing hydroxyapatite and eluting the adsorbed tPA species with different pH levels and salt concentrations. The second patent outlines a process of purifying tPA, specifically targeting tPA species with a molecular weight of about 70,000 daltons. This process involves using a cation exchanger and selectively separating the desired tPA species through a salt gradient elution method.

Career Highlights

Kunizou Mori is currently employed at Mitsui Toatsu Chemicals, Incorporated, where he continues to advance his research in biochemistry. His work has been instrumental in enhancing the understanding and application of tPA in various medical contexts.

Collaborations

Mori collaborates with esteemed colleagues, including Katsuyuki Suzuki and Noriko Morii. Their combined expertise contributes to the innovative research and development in the field of tissue plasminogen activator purification.

Conclusion

Kunizou Mori's contributions to the purification of tissue plasminogen activator highlight his role as an influential inventor in biochemistry. His patents reflect a commitment to advancing medical science and improving treatment methodologies.